Sort   by:  
 Page size 
UnknownInflammatory profile of patients with tuberculosis with or without HIV-1 co-infection: a prospective cohort study and immunological network analysis.
Not available
S-EPMC8357308 | biostudies-literature
UnknownMortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study.
Not available
S-EPMC8896764 | biostudies-literature
UnknownPharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.
Not available
S-EPMC4834590 | biostudies-literature
UnknownMechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers.
Not available
S-EPMC5332206 | biostudies-literature
UnknownDifferential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood.
Not available
S-EPMC5934482 | biostudies-literature
MetabolomicsSubcellular antibiotic visualization reveals a dynamic drug reservoir in infected macrophages
Tuberculosis, caused by the intracellular pathogen Mycobacterium tuberculosis, remains the world's deadliest infectious disease. Sterilizing chemotherapy requires at least 6 months of multidrug therapy. Difficulty visualizing the subcellular localization of antibiotics in infected host cells means t...
2020-12-07 | MTBLS959 | MetaboLights
UnknownPlasma Biomarkers to Detect Prevalent or Predict Progressive Tuberculosis Associated With Human Immunodeficiency Virus-1.
Not available
S-EPMC6603269 | biostudies-literature
UnknownEvaluation of miniaturized Illumina DNA preparation protocols for SARS-CoV-2 whole genome sequencing.
Not available
S-EPMC10132692 | biostudies-literature
UnknownEfficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial.
Not available
S-EPMC10682367 | biostudies-literature
ProteomicsControl of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation
The human cytomegalovirus (HCMV) US12 family consists of ten sequentially arranged genes (US12-21) with poorly characterized function. We now identify novel NK cell evasion functions for four members: US12, US14, US18 and US20. Using a systematic multiplexed proteomics approach to quantify ~1,300 c...
ORGANISM(S): Homo sapiens (Human) Human cytomegalovirus (HHV-5) (Human herpesvirus 5) 
2017-02-14 | PXD005883 | Pride
Multiplexed proteomics Cell surface Human cytomegalovirus Natural killer 
Sort   by:  
 Page size